Effect of Carvedilol on Heart functio

Not Applicable

• Conditions: Breast cancer.; Malignant neoplasm of breast; C50-C50

• Registration Number: IRCT2015062922968N1
• Lead Sponsor: Vice Chancellor for research of Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

inclusion criteria:
all of patient with breast cancer candidate for Herceptin therapy without attention to previous chemotherapy that have Ejection Fraction >50% and normal diastolic function or mild dysfunction
exclusion criteria:patient who have contraindication for Carvedilol;grade 2or 3 AV block; Heart rate <50;systolic blood pressure<90;Asthma;chronic obstructive pulmonary disease ;liver cirrhosis;psoriasis; peripheral vascular disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eft ventriculare dysfunction. Timepoint: Before chemotherapy and 3-6-12 month after thet. Method of measurement: Echocardiography.